The expression of heme oxygenase-1 induced by lansoprazole

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 1, 2009, Pages 9-13

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Heme Oxygenase 1 (HO 1); Lansoprazole; NF E2 reiated factor 2 (Nrf2)

Indexed keywords

HEME OXYGENASE 1; LANSOPRAZOLE; TRANSCRIPTION FACTOR NRF2;

ANTIINFLAMMATORY ACTIVITY; EPITHELIUM CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STOMACH EPITHELIUM; UPREGULATION;

RATTUS;

EID: 67849090150     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.SR09-28     Document Type: Review

References (33)

1. Maines, M.D.: The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 37, 517-554, 1997.
2. Sassa, S.: Biological implications of heme metabolism. J. Clin. Biochem. Nutr., 38, 138-155, 2006.
3. Shibahara, S.: Regulation of heme oxygenase gene expression. Semin. Hematol., 25, 370-376, 1988.
4. Nakao, A., Kaczorowski, D.J., Sugimoto, R., Billiar, T.R., and McCurry, K.R.: Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J. Clin. Biochem. Nutr., 42, 78-88, 2008.
5. Takahashi, T., Shimizu, H., Morimatsu, H., Maeshima, K., Inoue, K., Akagi, R., Matsumi, M., Katayama, H., and Morita, K.: Heme Oxygenase-1 is an essential cytoprotective component in oxidative tissue injury induced by hemorrhagic shock. J. Clin. Biochem. Nutr., 44, 28-40, 2009.
6. Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A.M., and Cook, J.L.: Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem., 274, 26071-26078, 1999.
7. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., and Yamamoto, M.: Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem., 275, 16023-16029, 2000.
8. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., and Yamamoto, M.: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev., 13, 76-86, 1999. (Pubitemid 29045117)
9. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., and Yamamoto, M.: Keap1 regulates both cytoplasmic- nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells, 8, 379-391, 2003. (Pubitemid 36504013)
10. Wild, A.C., Moinova, H.R., and Mulcahy, R.T.: Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem., 274, 33627-33636, 1999.
11. Jeong, S.O., Oh, G.S., Ha, H.Y., Soon Koo, B., Sung Kim, H., Kim, Y.C., Kim, E.C., Lee, K.M., Chung, H.T., and Pae, H.O.: Dimethoxycurcumin, a Synthetic Curcumin Analogue, Induces Heme Oxygenase-1 Expression through Nrf2 Activation in RAW264.7 Macrophages. J. Clin. Biochem. Nutr., 44, 79-84, 2009.
12. Ryter, S.W. and Choi, A.M.: Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid. Redox Signal, 7, 80-91, 2005.
13. Sekhar, K.R., Yan, X.X., and Freeman, M.L.: Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene, 21, 6829-6834, 2002.
14. He, C.H., Gong, P., Hu, B., Stewart, D., Choi, M.E., Choi, A.M., and Alam, J.: Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem., 276, 20858-20865, 2001.
15. Bloom, D.A. and Jaiswal, A.K.: Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem., 278, 44675-44682, 2003.
16. Huang, H.C., Nguyen, T., and Pickett, C.B.: Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem., 277, 42769-42774, 2002.
17. Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., and Yoshida, T.: Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol., 285, C334-C342, 2003.
18. Garnett, W.R.: Lansoprazole: a proton pump inhibitor. Ann. Pharmacother., 30, 1425-1436, 1996.
19. Langtry, H.D. and Wilde, M.I.: Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Drugs, 56, 447-486, 1998.
20. Wolfe, M.M. and Sachs, G.: Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology, 118, S9-S31, 2000.
21. Zimmermann, A.E. and Katona, B.G.: Lansoprazole: a comprehensive review. Pharmacotherapy, 17, 308-326, 1997.
22. Fellenius, E., Berglindh, T., Sachs, G., Olbe, L., Elander, B., Sjöstrand, S.E., and Wallmark, B.: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H++ K+) ATPase. Nature, 290, 159-161, 1981. (Pubitemid 11149696)
23. Yoshida, N., Uchiyama, K., Kuroda, M., Sakuma, K., Kokura, S., Ichikawa, H., Naito, Y., Takemura, T., Yoshikawa, T., and Okanoue, T.: Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol., 39, 816-822, 2004.
24. Suzuki, M., Suzuki, H., and Hibi, T.: Proton pump inhibitors and gastritis. Clin. Biochem. Nutr., 42, 71-75, 2008.
25. Ichikawa, H., Yoshida, N., Takagi, T., Tomatsuri, N., Katada, K., Isozaki, Y., Uchiyama, K., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World J. Gastroenterol., 10, 2814-2817, 2004.
26. Kuroda, M., Yoshida, N., Ichikawa, H., Takagi, T., Okuda, T., Naito, Y., Okanoue, T., and Yoshikawa, T.: Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin- induced rat enteritis. Int. J. Mol. Med., 17, 89-93, 2006.
27. Hendriks, J.J., Rester, A.D., Donckerwolcke, R., Forget, P.P., and Wouters, E.F.: Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis. Pediatr. Pulmonol., 31, 59-66, 2001.
28. Becker, J.C., Grosser, N., Waltke, C., Schulz, S., Erdmann, K., Domschke, W., Schröder, H., and Pohle, T.: Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem. Biophys. Res. Commun., 345, 1014-1021, 2006.
29. Isomoto, H., Nishi, Y., Kanazawa, Y., Shikuwa, S., Mizuta, Y., Inoue, K., and Kohno, K.: Immune and Inflammatory Responses in GERD and Lansoprazole. Clin. Biochem. Nutr., 41, 84-91, 2007.
30. Handa, O., Naito, Y., Takagi, T., Shimozawa, M., Kokura, S., Yoshida, N., Matsui, H., Cepinskas, G., Kvietys, P.R., and Yoshikawa, T.: Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-kappaB. J. Pharmacol. Exp. Ther., 309, 670-676, 2004.
31. Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., and Kondo, M.: A new mechanism for antiinflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther., 14, S74-S81, 2000.
32. Naito, Y.: Anti-inflammatory and anti-oxidant properties of proton pump inhibitors. Clin. Biochem. Nutr., 41, 82-83, 2007.
33. Takagi, T., Naito, Y., Okada, H., Ishii, T., Kajikawa, H., Mizushima, K., Akagiri, S., Adachi, S., Handa, O., Kokura, S., Ichikawa, H., Itoh, K., Yamamoto, M., Matsui, H., and Yoshikawa, T.: Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of Nrf2 and oxidation of keapl. J. Pharmacol. Exp. Ther., 2009, in preparation.